Gene · 407009
Papers2,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA-phytochemical interactome targeting thioredoxin-interacting protein: a narrative review at the nexus of RNA therapeutics, cancer biology, and metabolic regulation. | Front Oncol | 2026 | 42712981 | PubTator, text mining | PubMed |
| MicroRNA-224 orchestrates BMP and TGFβ signaling and is a therapeutic target in preclinical pulmonary arterial hypertension. | Sci Transl Med | 2026 | 42685153 | PubTator, text mining | PubMed |
| Exploratory analysis of circulating miRNA-100 and its association with eosinophilia in pediatric allergic rhinitis. | Otolaryngol Pol | 2026 | 42578832 | PubTator, text mining | PubMed |
| Near-infrared/glutathione-activated CRISPR/Cas13a sensing platform for the detection of multiple microRNAs. | RSC Adv | 2026 | 42395760 | PubTator, text mining | PubMed |
| Silent Messengers: The Role of Extracellular Vesicle-Associated miRNAs in the Non-Invasive Profiling of Hepatocellular Carcinoma. | Biomedicines | 2026 | 42351746 | PubTator, text mining | PubMed |
| Can alterations in miR-21, miR-1, and miR-224 expression predict personalized medicine chemotherapy in non-small cell lung cancer? | Mol Biol Rep | 2026 | 42268452 | PubTator, text mining | PubMed |
| miR-221/222, miR-224, and miR-339 are Overexpressed as Potential Biomarkers in Follicular Thyroid Neoplasms. | Indian J Surg Oncol | 2026 | 42221262 | PubTator, text mining | PubMed |
| ANKFN1 in skin fibroblasts may modulate mast cell activity and is associated with dupilumab response in atopic dermatitis. | Immunol Res | 2026 | 42062651 | PubTator, text mining | PubMed |
| Multifunctional double hairpin DNA polydopamine nano-system for "switch-on" detection and intervention of high-grade dysplastic nodules. | Mikrochim Acta | 2026 | 42053823 | PubTator, text mining | PubMed |
| Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma. | Med Sci (Basel) | 2026 | 41892825 | PubTator, text mining | PubMed |
| GNMT and Its Regulatory MicroRNAs as Biomarkers and Therapeutic Targets for Metabolic Dysfunction-Associated Fatty Liver Disease and Hepatocellular Carcinoma. | Int J Mol Sci | 2026 | 41828318 | PubTator, text mining | PubMed |
| X chromosome-encoded microRNAs in immune regulation: sex differences and clinical implications. | Front Glob Womens Health | 2026 | 41799158 | PubTator, text mining | PubMed |
| Ferroptosis in cardiovascular diseases: molecular mechanisms and a novel therapeutic target. | Mol Biomed | 2026 | 41795043 | PubTator, text mining | PubMed |
| JAK-STAT signaling: molecular mechanism and targeted treatment in dento-maxillofacial abnormalities. | Int J Oral Sci | 2026 | 41781377 | PubTator, text mining | PubMed |
| Pulp-Dentin Regeneration via Cell Homing: Current Evidence and Perspectives on Cell-Free Regenerative Endodontic Therapy. | Medicina (Kaunas) | 2026 | 41752774 | PubTator, text mining | PubMed |
| Transcriptomic Profiling of MicroRNA and Non-Coding RNA from Whole Blood of African Americans with MASLD. | Int J Mol Sci | 2026 | 41751802 | PubTator, text mining | PubMed |
| The Role of Raf Kinase Inhibitor Protein (RKIP) in HER2+ Breast Cancer Immune Evasion. | Cells | 2026 | 41744762 | PubTator, text mining | PubMed |
| PCMTD1-127aa suppresses osteosarcoma progression by competitively binding to USP10 to promote c-MYC degradation. | iScience | 2026 | 41732254 | PubTator, text mining | PubMed |
| Current insights into circulating biomarkers and their potential for predicting adolescent idiopathic scoliosis progression. | Front Cell Dev Biol | 2026 | 41727319 | PubTator, text mining | PubMed |
| MicroRNAs and suicidality: a systematic review and bioinformatic evaluation. | Front Psychiatry | 2026 | 41696473 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407009/papers